|
[1]
|
Gruber-Bzura, B.M. (2018) Vitamin D and Influenza-Prevention or Therapy? International Journal of Molecular Sciences, 19, E2419. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Jones, G. (2012) Vitamin D Safety: Its Mechanisms and Application. Standardy Medyczne, Pediatria, 9, 605-609.
|
|
[3]
|
Kim, D. (2017) The Role of Vitamin D in Thyroid Diseases. International Journal of Molecular Sciences, 18, 1949. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Beard, J.A., Bearde, A. and Striker, R. (2011) Vitamin D and the Anti-Viral State. Journal of Clinical Virology, 50, 194-200. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
钟康华, 邹燕桃, 陈羲, 等. 人类抗菌肽CAMP基因的转录调控[J]. 广东医学, 2018, 39(8): 1249-1251.
|
|
[6]
|
郝丽梅, 吴金辉, 田涛, 等. 抗菌肽在生物防护领域中的应用[J]. 中华预防医学杂志, 2009, 43(3): 245-247.
|
|
[7]
|
Sassi, F., Tamone, C. and D’Amelio, P. (2018) Vitamin D: Nutrient, Hormone, and Immunomodulator. Nutrients, 10, E1656. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Xhindoli, D., Pacor, S., Benincasa, M. et al. (2016) The Human Cathelicidin LL-37-A Pore-Forming Antibacterial Peptide and Host-Cell Modulator. Biochimica et Biophysica Acta, 1858, 546-566. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wang, T.T., Nestel, F.P., Bourdeau, V., et al. (2004) Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression. Journal of Immunology, 173, 2909-2912. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Gombart, A.F., Borregaard, N. and Koeffler, H.P. (2005) Human Cathelicidin Antimicrobial Peptide (CAMP) Gene Is Adirect Target of the Vitamin D Receptor and Is Strongly up-Regulated in Myeloid Cells by 1,25-Dihydroxyvitamin D3. The FASEB Journal, 19, 1067-1077. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Dai, X., Sayama, K., Tohyama, M., et al. (2010) PPAR Mediates Innate Immunity by Regulating the 1α,25-Dihydroxyvitamin D3 Induced hBD-3 and Cathelicidin in Human Keratinocytes. Journal of Dermatological Science, 60, 179-186. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Liu, P.T., Stenger, S., Tang, D.H., et al. (2007) Cutting Edge: Vitamin D-Mediated Human Antimicrobial Activity against Mycobacterium Tuberculosis Is Dependent on the Induction of Cathelicidin. Journal of Immunology, 179, 2060-2063. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
White, J.H. (2010) Vitamin D as an Inducer of Cathelicidin Antimicrobial Peptide Expression: Past, Present and Future. Journal of Steroid Biochemistry and Molecular Biology, 121, 234-238. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Bursuker, I. and Goldman, R. (1983) On the Origin of Macrophage Heterogeneity: A Hypothesis. Journal of the Reticuloendothelial Society, 33, 207-220.
|
|
[15]
|
Krutzik, S.R., Hewison, M., Liu, P.T., et al. (2008) IL-15 Links TLR2/1-Induced Macrophage Differentiation to the Vitamin D-Dependent Antimicrobial Pathway. Journal of Immunology, 181, 7115-7120. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Kim, E.W., Teles, R.M.B., Haile, S., et al. (2018) Vitamin D Status Contributes to the Antimicrobial Activity of Macrophages against Mycobacterium Leprae. PLoS Neglected Tropical Diseases, 12, e0006608. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
张晓丹, 赵贝, 李光慧, 等. 维生素D缺乏与感染发生的相关性及其机制研究进展[J]. 中国药房, 2018, 29(5): 710-715.
|
|
[18]
|
王博玉, 柏金秀, 贾浩, 等. 儿童反复上呼吸道感染与血浆抗菌肽LL-37及维生素D水平的相关性研究[J]. 中国儿童保健杂志, 2019, (8): 913-916.
|
|
[19]
|
吴桂辉, 黄涛, 罗槑, 等. 不同类型肺结核患者外周血维生素D与抗菌肽LL-37表达水平的研究[J]. 中国防痨杂志, 2019, 41(2): 190-194.
|
|
[20]
|
纪永佳, 黄列, 白华, 等. 新生儿败血症血清中25-羟基维生素D与抗菌肽-37的水平及25-羟基维生素D的影响因素[J]. 宁夏医科大学学报, 2018, 40(5): 542-545+551.
|
|
[21]
|
罗光燕, 杨小琼, 张芸, 等. 25羟维生素D3与抗菌肽在反复上呼吸道感染中的作用研究及相关性分析[J]. 重庆医学, 2016, 45(29): 4053-4055+4058.
|
|
[22]
|
刘钢铁, 薛月玲, 杨爱青, 等. 毛细支气管炎患儿血清25-(OH)D3、LL-37水平变化及意义[J]. 山东医药, 2016, 56(8): 75-77.
|
|
[23]
|
Quraishi, S.A., Pascale, G.D., Needleman, J.S., et al. (2015) Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo Controlled Trial. Critical Care Medicine, 43, 1928-1937. [Google Scholar] [CrossRef]
|